Medicalgorithmics has signed an agreement with PARP. The company will receive PLN 9.4 million for the development of a project based on VCAST technology
Medicalgorithmics, a Warsaw Stock Exchange-listed developer of globally innovative AI solutions for the cardiology industry, has signed an agreement with PARP to support its innovative Kardiobeat.CT project. Under the agreement, the Company will receive PLN 9.4 million in funding from PARP to support the project as part of the SMART Path initiative. The aim of this innovative Polish medtech project is to create an innovative diagnostic tool for the automatic detection and assessment of atherosclerotic plaques. The new project covers research and development work on artificial intelligence algorithms for the automatic analysis of cardiac CT images. The Company’s selection by PARP for the project was announced in July this year, and its total value is PLN 19.1 million.